A. Niesteruk

Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS‐CoV‐2 Genome

H. Schwalbe, K. Azzaoui, U. Scheffer, 2021, Angewandte Chemie.

Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS‐CoV‐2 Genome

H. Schwalbe, K. Azzaoui, U. Scheffer, 2021, Angewandte Chemie.

Structural characterization of the intrinsically disordered domain of Mycobacterium tuberculosis protein tyrosine kinase A

H. Schwalbe, C. Richter, H. R. Jonker, 2018, FEBS letters.

Oxidation of the Mycobacterium tuberculosis key virulence factor protein tyrosine phosphatase A (MptpA) reduces its phosphatase activity

H. Schwalbe, C. Richter, H. R. Jonker, 2022, FEBS letters.

The domain architecture of PtkA, the first tyrosine kinase from Mycobacterium tuberculosis, differs from the conventional kinase architecture

H. Schwalbe, C. Richter, H. R. Jonker, 2018, The Journal of Biological Chemistry.

Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space for Drug Development

D. Laurents, J. Hoch, K. Saxena, 2022, Angewandte Chemie.

19F NMR‐Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter‐Screens

H. Schwalbe, K. Azzaoui, B. Fürtig, 2020, Chembiochem : a European journal of chemical biology.